Senseonics Eversense 365 Shows Strong One-Year CGM Results
BARCELONA, Spain, March 14, 2026 New real-world evidence presented at the 19th International Conference on Advanced Technologies & Treatments...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology oncology innovation Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory compliance targeted therapy
BARCELONA, Spain, March 14, 2026 New real-world evidence presented at the 19th International Conference on Advanced Technologies & Treatments...
BARCELONA, Spain, March 14, 2026 Clinical-stage biopharmaceutical company Biomea Fusion has reported encouraging 52-week follow-up results from its Phase...
